154 related articles for article (PubMed ID: 35945449)
1. Phospholipase D2 controls bone homeostasis by modulating M-CSF-dependent osteoclastic cell migration and microtubule stability.
Kim HJ; Lee DK; Jin X; Che X; Ryu SH; Choi JY
Exp Mol Med; 2022 Aug; 54(8):1146-1155. PubMed ID: 35945449
[TBL] [Abstract][Full Text] [Related]
2. PDK1 is important lipid kinase for RANKL-induced osteoclast formation and function via the regulation of the Akt-GSK3β-NFATc1 signaling cascade.
Xiao D; Zhou Q; Gao Y; Cao B; Zhang Q; Zeng G; Zong S
J Cell Biochem; 2020 Nov; 121(11):4542-4557. PubMed ID: 32048762
[TBL] [Abstract][Full Text] [Related]
3. Regulation of osteoclast apoptosis and motility by small GTPase binding protein Rac1.
Fukuda A; Hikita A; Wakeyama H; Akiyama T; Oda H; Nakamura K; Tanaka S
J Bone Miner Res; 2005 Dec; 20(12):2245-53. PubMed ID: 16294277
[TBL] [Abstract][Full Text] [Related]
4. Specific targeting of PKCδ suppresses osteoclast differentiation by accelerating proteolysis of membrane-bound macrophage colony-stimulating factor receptor.
Kim MY; Lee K; Shin HI; Jeong D
Sci Rep; 2019 May; 9(1):7044. PubMed ID: 31065073
[TBL] [Abstract][Full Text] [Related]
5. Antiosteoclastic bone resorption activity of osteoprotegerin via enhanced AKT/mTOR/ULK1-mediated autophagic pathway.
Zhao H; Sun Z; Ma Y; Song R; Yuan Y; Bian J; Gu J; Liu Z
J Cell Physiol; 2020 Mar; 235(3):3002-3012. PubMed ID: 31535378
[TBL] [Abstract][Full Text] [Related]
6. Deficiency in the phosphatase PHLPP1 suppresses osteoclast-mediated bone resorption and enhances bone formation in mice.
Mattson AM; Begun DL; Molstad DHH; Meyer MA; Oursler MJ; Westendorf JJ; Bradley EW
J Biol Chem; 2019 Aug; 294(31):11772-11784. PubMed ID: 31189651
[TBL] [Abstract][Full Text] [Related]
7. The MET/Vascular Endothelial Growth Factor Receptor (VEGFR)-targeted Tyrosine Kinase Inhibitor Also Attenuates FMS-dependent Osteoclast Differentiation and Bone Destruction Induced by Prostate Cancer.
Watanabe K; Hirata M; Tominari T; Matsumoto C; Fujita H; Yonekura K; Murphy G; Nagase H; Miyaura C; Inada M
J Biol Chem; 2016 Sep; 291(40):20891-20899. PubMed ID: 27539855
[TBL] [Abstract][Full Text] [Related]
8. Phosphatidylinositol 3 kinase/Akt signal relay cooperates with smad in bone morphogenetic protein-2-induced colony stimulating factor-1 (CSF-1) expression and osteoclast differentiation.
Mandal CC; Ghosh Choudhury G; Ghosh-Choudhury N
Endocrinology; 2009 Nov; 150(11):4989-98. PubMed ID: 19819979
[TBL] [Abstract][Full Text] [Related]
9. Microtubule actin crosslinking factor 1 (MACF1) knockdown inhibits RANKL-induced osteoclastogenesis via Akt/GSK3β/NFATc1 signalling pathway.
Lin X; Xiao Y; Chen Z; Ma J; Qiu W; Zhang K; Xu F; Dang K; Qian A
Mol Cell Endocrinol; 2019 Aug; 494():110494. PubMed ID: 31260729
[TBL] [Abstract][Full Text] [Related]
10. The calcium channel TRPV6 is a novel regulator of RANKL-induced osteoclastic differentiation and bone absorption activity through the IGF-PI3K-AKT pathway.
Ma J; Zhu L; Zhou Z; Song T; Yang L; Yan X; Chen A; Ye TW
Cell Prolif; 2021 Jan; 54(1):e12955. PubMed ID: 33159483
[TBL] [Abstract][Full Text] [Related]
11. Psoralen and Bakuchiol Ameliorate M-CSF Plus RANKL-Induced Osteoclast Differentiation and Bone Resorption Via Inhibition of AKT and AP-1 Pathways in Vitro.
Chai L; Zhou K; Wang S; Zhang H; Fan N; Li J; Tan X; Hu L; Fan X
Cell Physiol Biochem; 2018; 48(5):2123-2133. PubMed ID: 30110702
[TBL] [Abstract][Full Text] [Related]
12. Class IA phosphatidylinositol 3-kinase regulates osteoclastic bone resorption through protein kinase B-mediated vesicle transport.
Shinohara M; Nakamura M; Masuda H; Hirose J; Kadono Y; Iwasawa M; Nagase Y; Ueki K; Kadowaki T; Sasaki T; Kato S; Nakamura H; Tanaka S; Takayanagi H
J Bone Miner Res; 2012 Dec; 27(12):2464-75. PubMed ID: 22806988
[TBL] [Abstract][Full Text] [Related]
13. Role of c-Src in cellular events associated with colony-stimulating factor-1-induced spreading in osteoclasts.
Insogna K; Tanaka S; Neff L; Horne W; Levy J; Baron R
Mol Reprod Dev; 1997 Jan; 46(1):104-8. PubMed ID: 8981371
[TBL] [Abstract][Full Text] [Related]
14. Urokinase receptor mediates osteoclastogenesis via M-CSF release from osteoblasts and the c-Fms/PI3K/Akt/NF-κB pathway in osteoclasts.
Kalbasi Anaraki P; Patecki M; Tkachuk S; Kiyan Y; Haller H; Dumler I
J Bone Miner Res; 2015 Feb; 30(2):379-88. PubMed ID: 25196912
[TBL] [Abstract][Full Text] [Related]
15. Thioacetamide promotes osteoclast transformation of bone marrow macrophages by influencing PI3K/AKT pathways.
Jin X; Li Y; Yang Y; Shen H; Chen J; Xu B; Xu J
J Orthop Surg Res; 2022 Jan; 17(1):53. PubMed ID: 35093114
[TBL] [Abstract][Full Text] [Related]
16. Neuromedin B and its receptor silencing suppresses osteoclast generation by modulating precursor proliferation via M-CSF/c-Fms/D-type cyclins.
Yeo CE; Kang WY; Seong SJ; Cho S; Lee HW; Yoon YR; Kim HJ
Exp Cell Res; 2017 Oct; 359(1):112-119. PubMed ID: 28780306
[TBL] [Abstract][Full Text] [Related]
17. c-Fms signaling mediates neurofibromatosis Type-1 osteoclast gain-in-functions.
He Y; Rhodes SD; Chen S; Wu X; Yuan J; Yang X; Jiang L; Li X; Takahashi N; Xu M; Mohammad KS; Guise TA; Yang FC
PLoS One; 2012; 7(11):e46900. PubMed ID: 23144792
[TBL] [Abstract][Full Text] [Related]
18. Mutation of Y179 on phospholipase D2 (PLD2) upregulates DNA synthesis in a PI3K-and Akt-dependent manner.
Di Fulvio M; Frondorf K; Gomez-Cambronero J
Cell Signal; 2008 Jan; 20(1):176-85. PubMed ID: 18006275
[TBL] [Abstract][Full Text] [Related]
19. Distinctive and selective route of PI3K/PKCα-PKCδ/RhoA-Rac1 signaling in osteoclastic cell migration.
Kim JM; Kim MY; Lee K; Jeong D
Mol Cell Endocrinol; 2016 Dec; 437():261-267. PubMed ID: 27576187
[TBL] [Abstract][Full Text] [Related]
20. Blocking of the Ubiquitin-Proteasome System Prevents Inflammation-Induced Bone Loss by Accelerating M-CSF Receptor c-Fms Degradation in Osteoclast Differentiation.
Lee K; Kim MY; Ahn H; Kim HS; Shin HI; Jeong D
Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28946669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
